The authors found that treatment with CSF from patients with ALS did not alter NSE levels in cultured rat motor neurons; thus, they concluded that the study failed to demonstrate the presence of toxic factors in the CSF from patients with ALS that would influence rat motor neurons. Here, ENO2 is linked to amyotrophic lateral sclerosis.